Back
Innovate Vs. AtriCure Industry Stock Comparison
Sell
20
VATE
Innovate
Last Price:
$6.25
Seasonality Move:
-11.45%
Sell
30
ATRC
AtriCure
Last Price:
$32.72
Seasonality Move:
4.85%
Sell
30
AtriCure (ATRC)
is a Sell
Is AtriCure a Buy, Sell or Hold?
-
ATRC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VATE Stock Price Chart
ATRC Stock Price Chart
VATE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 49.02 | Sell |
Chaikin Money Flow: | -39327 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.9 - 6.72) | Buy |
Bollinger Bands (100): | (5.4 - 10.28) | Sell |
ATRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 52.23 | Buy |
Chaikin Money Flow: | 110023 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.42 - 33.42) | Buy |
Bollinger Bands (100): | (31.19 - 38.71) | Sell |
VATE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.07 | Buy |
20-day SMA: | 6.38 | Sell |
50-day SMA: | 6.74 | Sell |
200-day SMA: | 6.35 | Sell |
8-day EMA: | 6.23 | Buy |
20-day EMA: | 6.31 | Buy |
50-day EMA: | 6.78 | Sell |
200-day EMA: | 7.18 | Sell |
ATRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.81 | Sell |
20-day SMA: | 31.74 | Buy |
50-day SMA: | 32.48 | Buy |
200-day SMA: | 32.24 | Buy |
8-day EMA: | 32.66 | Buy |
20-day EMA: | 32.26 | Buy |
50-day EMA: | 32.87 | Sell |
200-day EMA: | 32.81 | Sell |
Innovate Earnings Growth & VATE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AtriCure Earnings Growth & ATRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.05 per share, an increase this year of $0.23 per share, and an increase next year of $0.14 per share.
Innovate Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AtriCure Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |